MAYO CLINIC
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Conditions
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2011-05-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 42
- Registration Number
- NCT00482495
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
- Conditions
- Interventions
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 39
- Registration Number
- NCT00482378
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 89
- Registration Number
- NCT00477971
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2011-08-31
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 53
- Registration Number
- NCT00478218
- Locations
- 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Conditions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2011-05-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT00478075
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 33
- Registration Number
- NCT00477750
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00477815
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 103
- Registration Number
- NCT00474929
- Locations
- 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States
Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
- Conditions
- Interventions
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00470015
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery
- First Posted Date
- 2007-05-07
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00470379
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States